000 01393 a2200397 4500
005 20250518095806.0
264 0 _c20210621
008 202106s 0 0 eng d
022 _a1523-1755
024 7 _a10.1016/j.kint.2019.12.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcAdoo, Stephen P
245 0 0 _aSpleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model.
_h[electronic resource]
260 _bKidney international
_c06 2020
300 _a1196-1207 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
_xdrug therapy
650 0 4 _aAntibodies, Antineutrophil Cytoplasmic
650 0 4 _aGlomerulonephritis
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPeroxidase
650 0 4 _aRats
650 0 4 _aSyk Kinase
700 1 _aPrendecki, Maria
700 1 _aTanna, Anisha
700 1 _aBhatt, Tejal
700 1 _aBhangal, Gurjeet
700 1 _aMcDaid, John
700 1 _aMasuda, Esteban S
700 1 _aCook, H Terence
700 1 _aTam, Frederick W K
700 1 _aPusey, Charles D
773 0 _tKidney international
_gvol. 97
_gno. 6
_gp. 1196-1207
856 4 0 _uhttps://doi.org/10.1016/j.kint.2019.12.014
_zAvailable from publisher's website
999 _c30871934
_d30871934